Ligand Pharmaceuticals Inc (LGND)
EV/EBITDA
23.36×
TTM · Retrieved:
LGND EV/EBITDA
Current (TTM)23.36×retrieved
Current (TTM)23.36×retrieved
LGND Quarterly EV/EBITDA (-22.26× → 89.17×)
Latest values, visible window
High-resolution chart · PNG
LGND ev/ebitda history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EV/EBITDA |
|---|---|
| 89.1692× | |
| -301.241× | |
| 60.3301× | |
| 25.0478× | |
| 102.1708× | |
| -48.694× | |
| -66.2803× | |
| 526.2944× | |
| -27.4859× | |
| 10.3077× | |
| 46.1637× | |
| -291.1845× | |
| 94.89× | |
| 19.2079× | |
| 17.678× | |
| 38.8299× | |
| 45.3981× | |
| 200.7298× | |
| 270.6842× | |
| 71.6794× | |
| 69.5298× | |
| 76.8438× | |
| 62.2879× | |
| -1,197.0768× | |
| 38.0179× | |
| -70.2121× | |
| 74.2992× | |
| -303.4803× | |
| -339.167× | |
| 0.9365× | |
| -51.0233× | |
| 44.6226× | |
| 35.4001× | |
| 38.5928× | |
| 48.0244× | |
| 112.4142× | |
| 115.0933× | |
| 120.3216× | |
| 62.0939× | |
| 168.5566× | |
| 247.1502× | |
| 83.4675× | |
| 113.3798× | |
| 122.2349× | |
| 241.0548× | |
| 231.2028× | |
| 63.4242× | |
| 138.4703× | |
| 363.6437× | |
| 143.5704× | |
| 91.1634× | |
| 140.9226× | |
| 189.8352× | |
| 73.9275× | |
| 51.9434× | |
| -381.4141× | |
| -147.1368× | |
| -3,061.8287× | |
| 22.7876× | |
| -68.7196× | |
| -391.7097× | |
| -70.9166× | |
| -31.6714× | |
| -9.9461× | |
| -54.4412× | |
| -40.316× | |
| 165.7111× | |
| 115.9017× | |
| -69.9131× | |
| -40.7633× | |
| -1.9733× | |
| -30.1328× | |
| -22.4065× | |
| -15.0636× | |
| -27.7327× | |
| -31.5056× | |
| -24.4476× | |
| -8.2844× | |
| 57.012× | |
| -34.1925× | |
| -38.5279× | |
| -74.884× | |
| 151.5302× | |
| 3,745.2123× | |
| -259.208× | |
| -34.2487× | |
| -25.4043× | |
| -50.2475× | |
| -59.9452× | |
| -67.2483× | |
| 53.4861× | |
| -138.6066× | |
| -131.6019× | |
| -47.9773× | |
| -82.3148× | |
| -58.9269× | |
| -72.6906× | |
| -1,141.0279× | |
| -645.4223× | |
| -164.346× |